About PhRMA
The Pharmaceutical Research and Manufacturers of America (PhRMA) represents the country’s leading innovative biopharmaceutical research companies, which are laser focused on developing innovative medicines that transform lives and create a healthier world. Together, we are fighting for solutions to ensure patients can access and afford medicines that prevent, treat and cure disease. Over the last decade, PhRMA member companies have invested more than $850 billion in the search for new treatments and cures, and they support nearly five million jobs in the United States.
Connect with PhRMA
For information on how innovative medicines save lives, please visit:
www.PhRMA.org
www.VotersforCures.org
www.AmericasMedicines.com
www.Facebook.com/PhRMA
www.X.com/PhRMA
On November 21, PhRMA’s Chief Operating Officer, Lori Reilly, participated in WTOP’s webinar, “The Health Care Agenda 2024: Real Policies for Real People.” During the interview, Lori discussed the role PBMs and the 340B program play in driving up out-of-pocket medicine costs for patients, as well as policy solutions to expand patient access and affordability as the industry prepares for the next administration and Congress.
When:
Wednesday, November 21, at 10:30 AM ET
Speakers:
- Sarah Chavarria, President & CEO, Delta Dental of California
- Debbie Dingell, US Representative (D-MI)
- Neil Dunn, US Representative (R-FL)
- Diana Harshbarger, US Representative (R-TN)
- Greg Murphy, US Representative (R-NC)
- Lori Reilly, Chief Operating Officer, PhRMA
- Bruce Scott, MD, President, American Medical Association
- Mitchell Miller, Capitol Hill Correspondent, WTOP (Moderator)